23 June 2022 - EMA has recommended granting a marketing authorisation for COVID-19 Vaccine (inactivated, adjuvanted) Valneva for use in ...
23 June 2022 - EMA’s CHMP has recommended granting an extension of indication for the COVID-19 vaccine Nuvaxovid to include use ...
17 June 2022 - Speaking about the waiver, EFPIA Director General, Nathalie Moll said. “The decision is a serious retrograde step ...
17 June 2022 - EMA has started a rolling review for a version of Spikevax adapted to provide better protection ...
15 June 2022 - EMA has started a rolling review for a version of Comirnaty adapted to provide better protection ...
23 May 2022 - Approval follows CHMP recommendation for use in patients previously vaccinated with Vaxzevria or an EU approved ...
19 May 2022 - 2022 – Valneva today confirmed that the EMA has accepted the filing of a marketing authorisation ...
17 May 2022 - the EMA has endorsed a statement for health care professionals jointly developed by the International Coalition ...
16 May 2022 - Valneva today announced that it has received a notice from the European Commission of intent to ...
13 May 2022 - May 13, 2022 — Pfizer and BioNTech today announced they have reached an agreement with the European ...
2 May 2022 - Regulatory review in the United Kingdom is on-going as part of the European Commission Decision Reliance ...
29 April 2022 - The filing follows the European Medicines Agency's Committee for Medicinal Products for Human Use recent decision ...
6 April 2022 - The European Centre for Disease Prevention and Control and EMA’s COVID-19 task force have concluded that ...
31 March 2022 - If granted, Nuvaxovid COVID-19 vaccine (recombinant, adjuvanted) would be the first protein-based option for adolescents aged ...
30 March 2022 - The European Union's drug regulator has started reviewing Sanofi and its British partner GlaxoSmithKline's application seeking ...